Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C20H28O6S |
| Molecular Weight | 396.498 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 5 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(COC1=CSC=C1)\C=C\[C@H]2[C@H](O)C[C@H](O)[C@@H]2C\C=C/CCCC(O)=O
InChI
InChIKey=FYBFDIIAPRHIQS-JRSBLEPXSA-N
InChI=1S/C20H28O6S/c21-14(12-26-15-9-10-27-13-15)7-8-17-16(18(22)11-19(17)23)5-3-1-2-4-6-20(24)25/h1,3,7-10,13-14,16-19,21-23H,2,4-6,11-12H2,(H,24,25)/b3-1-,8-7+/t14?,16-,17-,18+,19-/m1/s1
Tiaprost is a synthetic analog of prostaglandin F2α (PGF2α) patented by Hoechst A.-G. as an estrus-synchronizing agent for veterinary medicine. Tiaprost treatment reduced the interval from calving to conception in multiparous cows, but it delayed conception and reduced the conception rate in primiparous cows. Treatment with tiaprost impaired reproductive performance in primiparous cows
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6428028
cows: 0.75 mg
Route of Administration:
Other
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C78568
Created by
admin on Mon Mar 31 19:15:33 GMT 2025 , Edited by admin on Mon Mar 31 19:15:33 GMT 2025
|
||
|
WHO-VATC |
QG02AD93
Created by
admin on Mon Mar 31 19:15:33 GMT 2025 , Edited by admin on Mon Mar 31 19:15:33 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m10848
Created by
admin on Mon Mar 31 19:15:33 GMT 2025 , Edited by admin on Mon Mar 31 19:15:33 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID901021711
Created by
admin on Mon Mar 31 19:15:33 GMT 2025 , Edited by admin on Mon Mar 31 19:15:33 GMT 2025
|
PRIMARY | |||
|
6441899
Created by
admin on Mon Mar 31 19:15:33 GMT 2025 , Edited by admin on Mon Mar 31 19:15:33 GMT 2025
|
PRIMARY | |||
|
SUB11012MIG
Created by
admin on Mon Mar 31 19:15:33 GMT 2025 , Edited by admin on Mon Mar 31 19:15:33 GMT 2025
|
PRIMARY | |||
|
4608
Created by
admin on Mon Mar 31 19:15:33 GMT 2025 , Edited by admin on Mon Mar 31 19:15:33 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104879
Created by
admin on Mon Mar 31 19:15:33 GMT 2025 , Edited by admin on Mon Mar 31 19:15:33 GMT 2025
|
PRIMARY | |||
|
C90931
Created by
admin on Mon Mar 31 19:15:33 GMT 2025 , Edited by admin on Mon Mar 31 19:15:33 GMT 2025
|
PRIMARY | |||
|
98E50HHH7M
Created by
admin on Mon Mar 31 19:15:33 GMT 2025 , Edited by admin on Mon Mar 31 19:15:33 GMT 2025
|
PRIMARY | |||
|
100000082180
Created by
admin on Mon Mar 31 19:15:33 GMT 2025 , Edited by admin on Mon Mar 31 19:15:33 GMT 2025
|
PRIMARY | |||
|
71116-82-0
Created by
admin on Mon Mar 31 19:15:33 GMT 2025 , Edited by admin on Mon Mar 31 19:15:33 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)